PHVS
PHVS
NASDAQ · Pharmaceuticals

Pharvaris Nv

$34.49
+1.96 (+6.03%)
As of Nov 7, 1:46 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -35.1% upside
Low Target $12.72
Average Target $22.40
High Target $29.92
Current Price $34.49
Current
$34.49
Target
$22.40
$12.72 $22.40 avg $29.92
Scenario Analysis
Bear Case
$12.72
-63.1%
Low target
Base Case
$22.40
-35.1%
Avg target
Bull Case
$29.92
+-13.3%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$43.25
-20.3% from high
52-Week Low
$21.02
+64.1% from low
Target vs 52W High
$22.40
-48.2% vs high
Next Earnings Report
Nov 18, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.74
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%